| 000 | 00850 a2200229 4500 | ||
|---|---|---|---|
| 005 | 20250516151007.0 | ||
| 264 | 0 | _c20130514 | |
| 008 | 201305s 0 0 eng d | ||
| 022 | _a1176-6336 | ||
| 024 | 7 |
_a10.2147/TCRM.S16079 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aSadaba, Belen | |
| 245 | 0 | 0 |
_aCritical appraisal of bilastine for the treatment of allergic rhinoconjunctivitis and urticaria. _h[electronic resource] |
| 260 |
_bTherapeutics and clinical risk management _c2013 |
||
| 300 |
_a197-205 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 700 | 1 | _aAzanza, Jose Ramon | |
| 700 | 1 | _aGomez-Guiu, Almundena | |
| 700 | 1 | _aRodil, Raquel | |
| 773 | 0 |
_tTherapeutics and clinical risk management _gvol. 9 _gp. 197-205 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2147/TCRM.S16079 _zAvailable from publisher's website |
| 999 |
_c22744800 _d22744800 |
||